InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Brown Scott B., Chief Financial Officer. Officer active across 1 companies, notably Tracon Pharmaceuticals, Inc.. In total, 3 filings have been recorded. Total volume traded: €9k. The latest transaction was disclosed on 29 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€2,5421,000 shares@ €2.542528.8% of flow
Common Stock
SEC:0001209191-22-021567:0·
Ideal exit: 24 Dec 2022 (T+270)
€3,1481,000 shares@ €3.148100.0% of flow
Common Stock
SEC:0001209191-21-051913·
Ideal exit: 10 May 2022 (T+270)
€3,1481,000 shares@ €3.14835.6% of flow
Common Stock
SEC:0001209191-21-051913:0·
Ideal exit: 10 May 2022 (T+270)
3 of 3 declarations
About Brown Scott B.
Scott B. Brown is Chief Financial Officer at Tracon Pharmaceuticals, Inc. He oversees the financial management of the company, including financial planning and reporting. His role is essential for ensuring the financial health and growth of the company.
